secwatch / observer
8-K filed October 14, 2025, 7:59 PM ET ticker MAIA CIK 0001878313
other material confidence high sentiment neutral materiality 0.50

MAIA Biotechnology announces $736,600 private placement of common stock and warrants

MAIA Biotechnology, Inc.

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

MAIA Biotechnology, Inc. issued 603,769_shares of common stock to certain accredited investors for $1.22 per share.

Security
common stock
Shares
603,769 shares
Purchaser
certain accredited investors
Consideration
$1.22 per share
Exact text from the filing
MAIA Biotechnology, Inc. (the “ Company ”) entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) with certain accredited investors (the “ Investors ”) for the issuance and sale in a private placement (the “ Private Placement ”) of: (i) 603,769_shares (the “ Investor Shares ”) of the Company’s common stock, par value $0.0001 per share (“ Common Stock ”), and (ii) warrants (the “ Investor Warrants ”) to purchase up to 603,769 shares of Common Stock, at a purchase price per Investor Share of $1.22, for an aggregate purchase price of approximately $736,600.
View on SEC.gov
Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

MAIA Biotechnology, Inc. issued up to 603,769 shares of Common Stock of warrant to certain accredited investors for $1.22 per share.

Security
warrant
Shares
up to 603,769 shares of Common Stock
Purchaser
certain accredited investors
Consideration
$1.22 per share
Exact text from the filing
MAIA Biotechnology, Inc. (the “ Company ”) entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) with certain accredited investors (the “ Investors ”) for the issuance and sale in a private placement (the “ Private Placement ”) of: (i) 603,769_shares (the “ Investor Shares ”) of the Company’s common stock, par value $0.0001 per share (“ Common Stock ”), and (ii) warrants (the “ Investor Warrants ”) to purchase up to 603,769 shares of Common Stock, at a purchase price per Investor Share of $1.22, for an aggregate purchase price of approximately $736,600.
View on SEC.gov

Browse all equity issuances →

MAIA Biotechnology, Inc. filing history →

Source: SEC EDGAR
accession 0001493152-25-017948
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.